Â鶹´«Ã½

Title: A novel way to understand and communicate the burden of Antipsychotic Prescribing for Adults across Specialist Intellectual Disability Services in England and Wales.

Chief Investigator: Professor Rohit Shankar , Faculty of Health, Â鶹´«Ã½

Title: Β-hydroxy β-methylbutyrate (HMB) supplementation to optimise outcomes in advanced liver cirrhosis: a multicentre double blind placebo controlled
randomised trial.

Chief Investigator: Professor Ashwin Dhanda , Faculty of Health, Â鶹´«Ã½

Title: How a medication called cannabidiol (brand name Epidyolex) affects adults who have certain rare and severe epilepsy conditions (Dravet syndrome, Lennox-Gastaut syndrome and tuberous sclerosis complex).

Chief Investigator: Professor Rohit Shankar , Â鶹´«Ã½

Title: Personalised social and self-management support for better living with multiple long-term conditions in the community.

Chief Investigator: , University of Southampton

Title: A feasibility randomised controlled trial, of administering daytime only enteral feeding compared to standard continuous enteral feeding, to reduce delirium in mechanically ventilated, critically ill adults.

Chief Investigator: Dr Jessie Welbourne , University Hospitals Â鶹´«Ã½ NHS Trust

Title: Dementia and Mild Cognitive Impairment in prison care pathway and training package: A realist informed feasibility study.

Chief Investigator: , University of Manchester

Title: D-PACT: Dementia PersonAlised Care Team  

Chief Investigator: Professor Richard Byng , Faculty of Health, Â鶹´«Ã½

Title: Realist informed mixed methods evaluation of the Dementia-Personalised Aligned Care Team intervention (D-PACT): a complex intervention for individuals with dementia and carers.

Chief Investigator: Professor Richard Byng , Faculty of Health, Â鶹´«Ã½

Title: A feasibility and definitive randomised controlled trial, with embedded realised informed process evaluation.

Chief Investigator: , University of Manchester

Title: Adapting the ENGAGE-PD physical activity coaching intervention for individuals newly diagnosed with Parkinson’s to be delivered by physiotherapists in NHS rehabilitation settings: a feasibility cluster-randomised controlled trial utilising co-design, implementation science principles, and an embedded qualitative component.

Chief Investigator: Jonathan Gilby , School of Health Professions, Â鶹´«Ã½

Title: Randomised, Phase II open label study of Rituximab/Ibritinib vs Rituximab/Chemo in older patients with mantle cell lymphoma.

Chief Investigator: Dr David Lewis, University Hospitals Â鶹´«Ã½ NHS Trust

 

Title: Evaluating the efficacy of Remdesivir for the improvement of lung function, perfusion, and symptom profile in long-covid patients.

Chief Investigator: , University of Derby

Title: Does in-bed Cycling delivered within 48 hours of mechanical ventilation, rEduce the occurrence of Delirium in critically ill patients: A mixed-methods Feasibility Randomised controlled trial protocol.

Chief Investigator: Jacqueline Bennion

Title: Establishing a biobank and database as a national resource for characterising indolent and aggressive forms of mantle cell lymphoma.

Chief Investigator: Dr David Lewis, University Hospitals Â鶹´«Ã½ NHS Trust

/ Janssen Pharmaceuticals

MCL Biobank observational study protocol  

Title: A randomized phase II trial evaluating Ibrutinib plus CD20 Ab and Ibrutinib-Venetoclax plus CD20 Ab in patients with untreated mantle cell lymphoma.

Chief Investigator: Professor Steven Le Gouill, Institut Curie – Paris

Associate Coordinating Investigator: Dr David Lewis, University Hospitals Â鶹´«Ã½ NHS Trust

Title: How are treatment outcomes for people with severe obesity ImPROved by GROUP-based behavioural intervention?

Chief Investigator: Professor Jonathan Pinkney , Faculty of Health, Â鶹´«Ã½

Press release  

Title: RAtionalising Psychotropic medications for adults with Intellectual Disabilities: sCOPing

Chief Investigator: , Imperial College London

Title: Older people with intellectual disabilities and epilepsy – recognising and correcting anticholinergic inducing polypharmacy

Chief Investigator: Professor Rohit Shankar , Faculty of Health, Â鶹´«Ã½

Title: Neuropsychiatric Research Databases for People with Intellectual Disabilities and Epilepsy.

Chief Investigator: Professor Rohit Shankar , Faculty of Health, Â鶹´«Ã½

Title: nutRition intervEntions For malnouRished oldEr adultS in care Homes: a parallel, superiority, three-arm cluster randomised controlled trial.

Joint Chief Investigator: Professor Mary Hickson , Faculty of Health, Â鶹´«Ã½

Joint Chief Investigator: , Bournemouth University

Title: Repurposing anti-retroviral drugs to treat NF2 related tumours

Chief Investigator: Professor Oliver Hanemann , Faculty of Health, Â鶹´«Ã½

Title: A randomised controlled trial to evaluate the effectiveness and cost effectiveness of SAFE (Systemic Autism-related Family Enabling), an intervention for families of autistic children.

Chief Investigator: Dr Becky Stancer, Faculty of Health, Â鶹´«Ã½

Title: The Efficacy of Peroneal Nerve Functional Electrical STimulation (FES) for the Reduction of Bradykinesia in Parkinson’s DiSease: An Assessor Blinded Randomised Controlled Trial

Chief Investigator: Professor Paul Taylor, Salisbury NHS Foundation Trust

Title: The South West Impact of Multiple Sclerosis (SWIMS) project – a patient-orientated longitudinal study of the impact of multiple sclerosis in South West England.

Chief Investigator: Professor Jeremy Hobart , Faculty of Health, Â鶹´«Ã½